Video

Vivian Fonseca From Tulane University: Great Progress Made In Diabetes Treatment

Author(s):

When diabetes first became a concern in the medical community the numbers were lower, but the consequences were much more severe. Today, many more people are diagnosed with types one and two diabetes but the treatment options are much safer and more effective.

%jwplayer%

When diabetes first became a concern in the medical community the numbers were lower, but the consequences were much more severe. Today, many more people are diagnosed with types one and two diabetes but the treatment options are much safer and more effective.

Vivian A. Fonseca, MD, who specializes in diabetes at Tulane University said a considerable amount of work has been done at the Louisiana institution to help treat this condition but that more work remains to be done. Fonseca noted that while amputation was at one time a common treatment practice it has been used much less regularly in recent years.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.